BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17643883)

  • 1. Urinary prostaglandin E2 in the newborn and infant.
    Antonucci R; Cuzzolin L; Arceri A; Fanos V
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):1-13. PubMed ID: 17643883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAIDs, prostaglandins and the neonatal kidney.
    Antonucci R; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():23-6. PubMed ID: 19701861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary PGE(2) concentrations measured by a new EIA method in infants with urinary tract infections or renal malformations.
    Cuzzolin L; Mangiarotti P; Fanos V
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):317-22. PubMed ID: 11427041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of lipid mediators in kidney injury.
    Hao CM; Breyer MD
    Semin Nephrol; 2007 May; 27(3):338-51. PubMed ID: 17533010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of growth hormone on renal regulation of electrolyte and water homeostasis.
    Dimke H; Flyvbjerg A; Frische S
    Growth Horm IGF Res; 2007 Oct; 17(5):353-68. PubMed ID: 17560155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal physiology. Part II: Fluid and electrolyte regulation.
    Seaman SL
    Neonatal Netw; 1995 Aug; 14(5):5-11. PubMed ID: 7630333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants.
    Agostiniani R; Mariotti P; Cataldi L; Fanos V; Sani S; Zaccaron A; Cuzzolin L
    Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):373-7. PubMed ID: 12468257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E(2)-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release.
    Nicolete R; Lima Kde M; Júnior JM; Jose PJ; Sanz MJ; Faccioli LH
    Eur J Pharm Biopharm; 2008 Nov; 70(3):784-90. PubMed ID: 18640269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggression to the immature kidney].
    Guignard JP
    Pediatr Med Chir; 2002; 24(2):105-10. PubMed ID: 11987507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins in the kidney: developments since Y2K.
    Nasrallah R; Clark J; Hébert RL
    Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide differently affects prostaglandin E2 levels in fetal and maternal compartments of perfused human term placenta.
    Amash A; Holcberg G; Sheiner E; Fleisher-Berkovich S; Myatt L; Huleihel M
    Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):18-22. PubMed ID: 18812231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal development and neonatal adaptation.
    Saint-Faust M; Boubred F; Simeoni U
    Am J Perinatol; 2014 Oct; 31(9):773-80. PubMed ID: 24623338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acids differentially alter PGF(2alpha) and PGE(2) release from bovine trophoblast and endometrial tissues during short-term culture.
    Meier S; Ledgard AM; Sato TA; Peterson AJ; Mitchell MD
    Anim Reprod Sci; 2009 Apr; 111(2-4):353-60. PubMed ID: 18436399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy.
    Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C
    J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: implications for neurological diseases.
    Oliveira MS; Furian AF; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Calixto JB; Otalora LF; Garrido-Sanabria ER; Mello CF
    J Neurochem; 2009 Apr; 109(2):416-26. PubMed ID: 19200345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The kidneys and old age].
    Fliser D
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1835-8. PubMed ID: 18770483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants.
    DeWoskin RS; Thompson CM
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):66-86. PubMed ID: 18433959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine.
    Neale JR; Dean BJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):72-7. PubMed ID: 18632314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric kidney transplantation is safe and available for patients with urological anomalies as well as those with primary renal diseases.
    Morita K; Iwami D; Hotta K; Shimoda N; Miura M; Watarai Y; Hoshii S; Obikane K; Nakashima T; Sasaki S; Nonomura K
    Pediatr Transplant; 2009 Mar; 13(2):200-5. PubMed ID: 18662371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.